ccrn-20251209

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 9, 2025

Cross Country Healthcare, Inc.
(Exact name of registrant as specified in its charter)


Delaware	0-33169	13-4066229
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

5201 Congress Avenue, Suite 160, Boca Raton, FL 33487
(Address of Principal Executive Office) (Zip Code)
(561) 998-2232
(Registrant’s telephone number, including area code)
6551 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered

Common stock, par value $0.0001 per share CCRN The Nasdaq Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.07 Submission of Matters to a Vote of Security Holders

(a) On December 9, 2025, the Company held its Annual Meeting of Stockholders (“Annual Meeting”).

(b) The following items of business were voted upon by stockholders at the Annual Meeting:

(i) A proposal to elect the directors listed below for a one-year term ending in 2026 or until their successors are duly

elected and qualified was approved with the following vote:


Director	For	Against	Abstentions	Broker Non-Votes
Kevin C. Clark	21,815,204	338,300	51,773	3,660,974
Dwayne Allen	20,339,789	1,813,719	51,769	3,660,974
Venkat Bhamidipati	22,128,592	24,912	51,773	3,660,974
W. Larry Cash	21,855,961	297,536	51,780	3,660,974
Gale Fitzgerald	19,502,475	2,651,031	51,771	3,660,974
John A. Martins	21,812,839	340,667	51,771	3,660,974
Dr. Janice E. Nevin, MD, MPH	21,846,039	299,194	60,044	3,660,974

(ii) The ratification of the appointment of Deloitte & Touche as the Company's independent registered public

accounting firm for the fiscal year ending December 31, 2025 was approved as follows:


For	Against	Abstentions	Broker Non-Votes
25,759,187	48,300	58,764	0

(iii) The compensation of named executive officers was approved, on an advisory (non-binding) basis, by the votes set

forth below:


For	Against	Abstentions	Broker Non-Votes
21,724,841	279,383	201,053	3,660,974

Item 9.01 Financial Statements and Exhibits

(d) Exhibits


			Exhibit						Description

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

CROSS COUNTRY HEALTHCARE, INC.

Dated:

December 11, 2025

By:

/s/ William J. Burns

Name: William J. Burns

Title: Executive Vice President & Chief Financial Officer

Cross Country Healthcare Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits